You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TNGX Sale Disclosure
Crystal Adam · SEC Form 4 · Filed Jun 3, 2026
Sale
Calculated transaction value
$480.94K
Crystal Adam President, R&d
TNGX
Tango Therapeutics
TNGX
Transaction date
Jun 1, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed 2 days later
TNGX daily price context
Close on/before transaction
$23.1
Jun 1, 2026
First close after public filing
$22.15
Jun 4, 2026
30-day return after filing
+35.17%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 20,860 shares @ $23.06
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-255940
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$757.97K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Tango Therapeutics, Inc. TNGX | Exercise | Jun 1, 2026 | $140.4K |
| Tango Therapeutics, Inc. TNGX | Sale | Jun 1, 2026 | $136.63K |
| Tango Therapeutics, Inc. TNGX Current | Sale | Jun 1, 2026 | $480.94K |
| Tango Therapeutics, Inc. TNGX | Exercise | Jun 1, 2026 | $0 |